Individual Genome Sciences and GlaxoSmithKline have so far stayed mum on the aspects of their cope. But if the cope performs out according to the program of other latest big pharmaceutical products, Individual Genome Science’s authority might be on the way out. In the last significant pharma-bio acquistion of a Doctor organization, Amgen Inc. ingested up Rockville-based Micromet Inc. for $1.16 million. That cope saw the ouster of Micromet Chief professional and CEO Religious Itin and other professionals. In Qiagen NV's buy of Digene Corp. in 2007, CEO Evan Jackson separated methods with the producing organization to begin his own investment investment organization. And when U.K drugmaker AstraZeneca PLC purchased Gaithersburg-based MedImmune Inc. for $15.6 million in 2007, us president Mark Mott walked down a season later, later becoming a member of investment investment organization New Business Affiliates Inc. in Chevrolet Pursuit.
No comments:
Post a Comment